MDXG
MiMedx Group Inc
NASDAQ: MDXG · HEALTHCARE · BIOTECHNOLOGY
$3.36
+8.91% today
Updated 2026-04-30
Market cap
$458.33M
P/E ratio
9.64
P/S ratio
1.10x
EPS (TTM)
$0.32
Dividend yield
—
52W range
$3 – $8
Volume
1.4M
MiMedx Group Inc (MDXG) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $788874.00 | $7.76M | $27.05M | $59.18M | $118.22M | $187.30M | $245.01M | $321.14M | $359.11M | $359.11M | $248.23M | $242.02M | $267.84M | $321.48M | $348.88M | $418.63M |
| Revenue growth (YoY) | — | — | — | — | — | +883.7% | +248.6% | +118.8% | +99.8% | +58.4% | +30.8% | +31.1% | +11.8% | +0.0% | -30.9% | -2.5% | +10.7% | +20.0% | +8.5% | +20.0% |
| Cost of revenue | — | — | — | — | $1.72M | $3.15M | $5.19M | $9.33M | $12.66M | $20.20M | $32.41M | $35.22M | $36.39M | $36.39M | $39.33M | $39.63M | $48.32M | $54.63M | $60.07M | $73.01M |
| Gross profit | — | — | — | — | $-931189.00 | $4.61M | $21.87M | $49.85M | $105.56M | $167.09M | $212.61M | $285.92M | $322.73M | $322.73M | $208.90M | $202.39M | $219.53M | $266.84M | $288.81M | $345.62M |
| Gross margin | — | — | — | — | -118.0% | 59.4% | 80.8% | 84.2% | 89.3% | 89.2% | 86.8% | 89.0% | 89.9% | 89.9% | 84.2% | 83.6% | 82.0% | 83.0% | 82.8% | 82.6% |
| R&D | $100000.00 | $2.01M | $2.01M | $4.02M | $2.75M | $2.60M | $2.88M | $4.84M | $7.05M | $8.41M | $14.34M | $17.90M | $15.77M | $15.77M | $11.71M | $9.93M | $12.70M | $12.66M | $12.34M | $15.10M |
| SG&A | $600000.00 | $8.70M | $7.96M | $7.96M | $6.80M | $11.80M | $19.59M | $46.23M | $90.48M | $133.38M | $170.11M | $216.02M | $252.63M | $252.63M | $181.02M | $198.36M | $208.79M | $206.72M | $225.09M | $266.19M |
| Operating income | $-16148.00 | $-36809.00 | $-17.85M | $-11.98M | $-10.53M | $-9.76M | $-1.99M | $-2.64M | $7.10M | $24.36M | $884000.00 | $46.22M | $-3.92M | $-3.92M | $-45.40M | $-7.05M | $-14.73M | $37.12M | $58.87M | $63.89M |
| Operating margin | — | — | — | — | -1335.2% | -125.8% | -7.4% | -4.5% | 6.0% | 13.0% | 0.4% | 14.4% | -1.1% | -1.1% | -18.3% | -2.9% | -5.5% | 11.5% | 16.9% | 15.3% |
| EBITDA | $3852.00 | $463453.00 | $-10.83M | $-10.89M | $-9.71M | $-7.98M | $-146000.00 | $-550000.00 | $9.22M | $27.10M | $8.93M | $52.58M | $2.99M | $17.59M | $-37.52M | $-1.89M | $-10.68M | $40.54M | $65.35M | $82.93M |
| EBITDA margin | — | — | — | — | -1230.6% | -102.8% | -0.5% | -0.9% | 7.8% | 14.5% | 3.6% | 16.4% | 0.8% | 4.9% | -15.1% | -0.8% | -4.0% | 12.6% | 18.7% | 19.8% |
| EBIT | $-16148.00 | $-36809.00 | $-11.33M | $-11.98M | $-10.82M | $-9.76M | $-1.99M | $-2.24M | $7.10M | $24.36M | $3.46M | $46.81M | $-3.92M | $10.68M | $-44.37M | $-7.07M | $-14.73M | $37.12M | $59.31M | $68.05M |
| Interest expense | $590.00 | $2051.00 | $0.00 | $0.00 | $599649.00 | $432970.00 | $2.31M | $1.37M | $48000.00 | $86000.00 | $339000.00 | $87000.00 | $0.00 | $0.00 | $7.94M | $4.98M | $5.02M | $6.46M | $1.01M | $1.78M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-16738.00 | $-38860.00 | $-17.37M | $-11.92M | $-11.42M | $-10.19M | $-7.66M | $-4.11M | $6.22M | $29.45M | $11.97M | $64.73M | $-29.98M | $-29.98M | $-49.28M | $-12.30M | $-30.20M | $67.44M | $42.42M | $48.58M |
| Net income growth (YoY) | — | -132.2% | -44602.7% | +31.4% | +4.2% | +10.7% | +24.8% | +46.3% | +251.3% | +373.4% | -59.3% | +440.6% | -146.3% | +0.0% | -64.4% | +75.0% | -145.5% | +323.3% | -37.1% | +14.5% |
| Profit margin | — | — | — | — | -1447.6% | -131.4% | -28.3% | -6.9% | 5.3% | 15.7% | 4.9% | 20.2% | -8.3% | -8.3% | -19.9% | -5.1% | -11.3% | 21.0% | 12.2% | 11.6% |